Boston Scientific beats quarterly profit estimates on strength in heart devices unit
Medical device maker Boston Scientific topped Wall Street expectations for third-quarter profit on Thursday, helped by a resilient demand for its heart devices following the post-pandemic rebound i...
Boston Scientific may be shielded from weight-loss drugs hit by procedure recovery
Boston Scientific's quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical device maker could take a hit from the sur...
What's in Store for Boston Scientific (BSX) in Q3 Earnings?
With global staffing issues and the supply situation gradually improving, Boston Scientific's (BSX) international business is expected to have improved further in the third quarter.
The Pros Got It Wrong: 3 Stocks to Sell Despite Recent Upgrades
One tool that investors can easily access for any stock is analyst ratings. These ratings point you in the direction of stocks to buy and stocks to sell.
Boston Scientific's (BSX) Wavewriter Alpha SCS Gets FDA's Nod
Boston Scientific (BSX) receives the FDA's nod for an expanded indication of Wavewriter SCS Systems.
5 Medical Product Stocks to Buy Amid Industry Recovery
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, BSX, ZBH, PODD and HAE are well-p...
7 Affordable Stocks to Invest in as America's Population Ages
There's no doubt that America is aging. The numbers do not lie.
Here's Why You Should Invest in Boston Scientific (BSX) Now
Investors are optimistic about Boston Scientific (BSX) on consistent growth and upbeat guidance.
PBH or BSX: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers value investors a bet...
Boston Scientific Announces Conference Call Discussing Third Quarter 2023 Results
MARLBOROUGH, Mass. , Oct. 2, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quart...
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
Here is how Boston Scientific (BSX) and Conmed (CNMD) have performed compared to their sector so far this year.
Boston Scientific (BSX) Set to Acquire Relievant Medsystems
Boston Scientific's (BSX) new M&A deal is likely to broaden the Neuromodulation business portfolio.
Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payments
Boston Scientific Corp. BSX, +0.19% said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company that has developed a treatment for a form of...
Boston Scientific to pay $850 mln upfront to buy Relievant Medsystems
Boston Scientific said on Tuesday it would buy private medical tech company Relievant Medsystems for an upfront cash payment of $850 million.
PBH vs. BSX: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is ...
Related Companies